menopause
Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says
April 13, 2026Astellas Pharma, menopause
Final draft NICE guidance has recommended Veoza (fezolinetant), made by Astellas Pharma, to treat moderate to severe menopausal hot flushes …
Five Facts about the menopause
March 6, 2026Medical Communications Five Facts, HRT, menopause, perimenopause
1 Menopause is when periods stop due to decreasing hormone levels. It generally begins between the ages of 45 and …
Astellas Pharma shares positive results from phase 3b trial of Fezolinetant for menopause symptoms
June 28, 2023Medical Communications Astellas Pharma, Pharmacy, clinical trial, fezolinetant, menopause
Astellas Pharma has announced positive topline results from the phase 3b DAYLIGHT clinical trial for fezolinetant, its investigational oral, nonhormonal …
FDA approves new nonhormonal medication for menopause hot flashes
May 15, 2023Medical Communications FDA, HRT, Veozah, hot flashes, menopause
The US Food and Drug Administration (FDA) has announced its approval of Veozah (fezolinetant), an oral medication to treat moderate …
Bayer scoops up women’s healthcare biotech KaNDy Therapeutics in potential $1bn+ deal
August 11, 2020Manufacturing and Production, Research and Development, Sales and Marketing Bayer, KaNDy Therapeutics, menopause, pharma
Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced …
Novartis Kisqali shows superior survival rates to AstraZeneca’s Faslodex in advanced breast cancer
December 12, 2019Business Services Journal of Medicine, Novartis, menopause
Novartis Kisqali (ribociclib) plus fulvestrant demonstrated a statistically significant improvement in overall survival rates, with an almost 30% reduction in …
Astellas lines up Ogeda for acquisition in $853 million deal
April 3, 2017Sales and Marketing Astellas, Ogeda SA, menopause
Astellas, based in Tokyo, has announced that it has agreed a deal to acquire Belgium-based Ogeda SA. The deal will …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
